224 related articles for article (PubMed ID: 37660063)
1. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ
Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063
[TBL] [Abstract][Full Text] [Related]
2. Activation of Pyroptosis Using AIEgen-Based sp
Zhang L; Wan SC; Zhang J; Zhang MJ; Yang QC; Zhang B; Wang WY; Sun J; Kwok RTK; Lam JWY; Deng H; Sun ZJ; Tang BZ
J Am Chem Soc; 2023 Aug; 145(32):17689-17699. PubMed ID: 37550880
[TBL] [Abstract][Full Text] [Related]
3. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
4. Engineering Multienzyme-Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity.
Zhang L; Yang QC; Wang S; Xiao Y; Wan SC; Deng H; Sun ZJ
Adv Mater; 2022 Apr; 34(13):e2108174. PubMed ID: 34918837
[TBL] [Abstract][Full Text] [Related]
5. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis/pyroptosis dual-inductive combinational anti-cancer therapy achieved by transferrin decorated nanoMOF.
Xu R; Yang J; Qian Y; Deng H; Wang Z; Ma S; Wei Y; Yang N; Shen Q
Nanoscale Horiz; 2021 Apr; 6(4):348-356. PubMed ID: 33687417
[TBL] [Abstract][Full Text] [Related]
7. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Covalent Organic Frameworks with Cross-Linked Pores for Efficient Cancer Immunotherapy.
Zhang L; Yang LL; Wan SC; Yang QC; Xiao Y; Deng H; Sun ZJ
Nano Lett; 2021 Oct; 21(19):7979-7988. PubMed ID: 34525805
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy.
Liu D; Liang M; Tao Y; Liu H; Liu Q; Bing W; Li W; Qi J
Biomaterials; 2024 Sep; 309():122610. PubMed ID: 38749307
[TBL] [Abstract][Full Text] [Related]
10. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
11. Designing Single-Atom Active Sites on sp
Sun B; Wang X; Ye Z; Zhang J; Chen X; Zhou N; Zhang M; Yao C; Wu F; Shen J
Adv Sci (Weinh); 2023 May; 10(13):e2207507. PubMed ID: 36847061
[TBL] [Abstract][Full Text] [Related]
12. Covalent Organic Framework Nanobowls as Activatable Nanosensitizers for Tumor-Specific and Ferroptosis-Augmented Sonodynamic Therapy.
Zhang S; Xia S; Chen L; Chen Y; Zhou J
Adv Sci (Weinh); 2023 Feb; 10(6):e2206009. PubMed ID: 36594611
[TBL] [Abstract][Full Text] [Related]
13. A Photo-Activated Thermoelectric Catalyst for Ferroptosis-/Pyroptosis-Boosted Tumor Nanotherapy.
Jiang X; Yang M; Fang Y; Yang Z; Dai X; Gu P; Feng W; Chen Y
Adv Healthc Mater; 2023 Sep; 12(24):e2300699. PubMed ID: 37086391
[TBL] [Abstract][Full Text] [Related]
14. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
15. Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis.
Gao Y; Li Y; Cao H; Jia H; Wang D; Ren C; Wang Z; Yang C; Liu J
J Nanobiotechnology; 2022 Aug; 20(1):390. PubMed ID: 36045424
[TBL] [Abstract][Full Text] [Related]
16. A Bimetallic Polymerization Network for Effective Increase in Labile Iron Pool and Robust Activation of cGAS/STING Induces Ferroptosis-Based Tumor Immunotherapy.
Wang Z; Zhou P; Li Y; Zhang D; Chu F; Yuan F; Pan B; Gao F
Small; 2024 May; 20(20):e2308397. PubMed ID: 38072786
[TBL] [Abstract][Full Text] [Related]
17. A vinyl-decorated covalent organic framework for ferroptotic cancer therapy
Guan Q; Zhou LL; Zhou W; Dong YB
J Mater Chem B; 2022 Nov; 10(43):8894-8909. PubMed ID: 36260007
[TBL] [Abstract][Full Text] [Related]
18. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
19. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor.
Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H
Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells.
Wu Y; Pi D; Zhou S; Yi Z; Dong Y; Wang W; Ye H; Chen Y; Zuo Q; Ouyang M
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):587-600. PubMed ID: 37092860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
